Abstract
A case of Hodgkin's disease associated from the start with visceral leishmaniasis in the absence of antitumoral treatment shows that leishmaniasis is a severe opportunistic infection in endemic areas and can be masked by the tumoral syndrome of an underlying pathology. Conversely, patients with visceral leishmaniasis must be investigated for a cause of immunosuppression with, in particular, biopsy of accessible lymph nodes. The exceptionally favourable course of this particular case deserved to be high-lighted.
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols*
-
Antiprotozoal Agents / therapeutic use
-
Bleomycin / administration & dosage
-
Dacarbazine / administration & dosage
-
Doxorubicin / administration & dosage
-
Female
-
Hodgkin Disease / complications*
-
Hodgkin Disease / drug therapy
-
Humans
-
Immunocompromised Host*
-
Leishmaniasis, Visceral / complications*
-
Leishmaniasis, Visceral / drug therapy
-
Mechlorethamine / administration & dosage
-
Meglumine / therapeutic use
-
Meglumine Antimoniate
-
Opportunistic Infections / complications*
-
Organometallic Compounds / therapeutic use
-
Prednisone / administration & dosage
-
Procarbazine / administration & dosage
-
Vinblastine
-
Vincristine / administration & dosage
Substances
-
Antiprotozoal Agents
-
Organometallic Compounds
-
Bleomycin
-
Procarbazine
-
Mechlorethamine
-
Vincristine
-
Vinblastine
-
Meglumine
-
Meglumine Antimoniate
-
Dacarbazine
-
Doxorubicin
-
Prednisone
Supplementary concepts
-
ABVD protocol
-
MOPP protocol